Enhancing intracranial efficacy prediction of osimertinib in non-small cell lung cancer: a novel approach through brain MRI radiomics.

MLA

Tang, Xin, et al. “Enhancing Intracranial Efficacy Prediction of Osimertinib in Non-Small Cell Lung Cancer: A Novel Approach through Brain MRI Radiomics.” Frontiers in Neurology, vol. 15, Aug. 2024, p. 1399983. EBSCOhost, https://doi.org/10.3389/fneur.2024.1399983.

APA

Tang, X., Li, Y., Qian, W.-L., Han, P.-L., Yan, W.-F., & Yang, Z.-G. (2024). Enhancing intracranial efficacy prediction of osimertinib in non-small cell lung cancer: a novel approach through brain MRI radiomics. Frontiers in Neurology, 15, 1399983. https://doi.org/10.3389/fneur.2024.1399983

Chicago

Tang, Xin, Yuan Li, Wen-Lei Qian, Pei-Lun Han, Wei-Feng Yan, and Zhi-Gang Yang. 2024. “Enhancing Intracranial Efficacy Prediction of Osimertinib in Non-Small Cell Lung Cancer: A Novel Approach through Brain MRI Radiomics.” Frontiers in Neurology 15 (August): 1399983. doi:10.3389/fneur.2024.1399983.